secwatch.observer — SEC 8-K summary
======================================

Issuer:     Stereotaxis, Inc. (STXS)
CIK:        0001289340
Form:       8-K
Filed at:   2026-05-12T20:10:47+00:00
Accession:  0001493152-26-022488
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Stereotaxis reports Q1 revenue $6.3M, net loss $5.9M; guides FY26 rev >$40M; MAGiC FDA approved, Robocath acquisition
--------------------------------------------------------------------------------

- Revenue $6.3M vs $7.5M YoY; net loss $5.9M; cash $14.6M, no debt.
- MAGiC catheter (FDA approved Jan) and Synchrony system (FDA cleared Apr) now in commercial use.
- Definitive agreement to acquire Robocath, combining complementary robotic technologies.
- Guides FY26 revenue >$40M, double-digit growth; Q3 and Q4 each >$10M.
- Manufacturing ramp for MAGiC targets 500/month by year end; winding down J&J relationship.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1289340/000149315226022488/0001493152-26-022488-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1289340/000149315226022488/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-022488

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer